Dipexium Pharmaceuticals Inc. (NASDAQ:DPRX)’s share price was up 8.5% during mid-day trading on Wednesday . The company traded as high as $13.37 and last traded at $12.70, with a volume of 126,796 shares trading hands. The stock had previously closed at $11.71.

Separately, Zacks Investment Research cut shares of Dipexium Pharmaceuticals from a “hold” rating to a “sell” rating in a research report on Tuesday, May 24th.

The stock’s market capitalization is $132.05 million. The company’s 50 day moving average price is $11.27 and its 200-day moving average price is $10.12.

Dipexium Pharmaceuticals (NASDAQ:DPRX) last issued its earnings results on Thursday, August 4th. The company reported ($0.52) EPS for the quarter, topping analysts’ consensus estimates of ($0.54) by $0.02. Equities analysts forecast that Dipexium Pharmaceuticals Inc. will post ($2.10) EPS for the current fiscal year.

Dipexium Pharmaceuticals, Inc is a late-stage pharmaceutical company. The Company is focused on the development and commercialization of Locilex (pexiganan cream 0.8%), a first-in-class, broad spectrum, topical antibiotic. Locilex is focused on the treatment of mild infections of diabetic foot ulcers (Mild DFI).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.